← Leaderboards
Margaret Ziona Borok
University Of Colorado Denver
$994,127
Attributed
$994,127
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,952,834 · 4
By mechanism
U54$4,420,954 · 3
P20$531,880 · 1
Top collaborators
- Matthys Hendrik Botha5 shared
- Anna R Giuliano5 shared
- Thomas B. Campbell2 shared
- James Gita Hakim2 shared
- Edward Havranek2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Gabriela M Samayoa Reyes$802,427
- Katherine R Sabourin$1,582,113
- Thomas B. Campbell$27,628,296
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsZimbabwePersonsOncologyImmuneAids Related CancerHiv InfectionsViralAfricaCountryCancer BurdenPreventionFosteringResearch PersonnelInnovationMortalityPublic HealthAwardGermanyEducational WorkshopLow And Middle-Income CountriesLecturesDesignInstitution
Grant awards (16)
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)$594,901
U54 · FY2025 · CA
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)$264,938
U54 · FY2025 · CA
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)$213,772
U54 · FY2025 · CA
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe$99,152
U54 · FY2025 · CA · contact PI
Developmental & Career Enhancement Core$99,148
U54 · FY2025 · CA · contact PI
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe$97,124
U54 · FY2025 · CA · contact PI
Developmental & Career Enhancement Core$38,880
U54 · FY2025 · CA · contact PI
Developmental & Career Enhancement Core$17,519
U54 · FY2025 · CA · contact PI
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)$1,108,715
U54 · FY2024 · CA
Developmental & Career Enhancement Core$177,110
U54 · FY2024 · CA · contact PI
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe$123,960
U54 · FY2024 · CA · contact PI
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)$1,244,501
U54 · FY2023 · CA
Developmental & Career Enhancement Core$177,110
U54 · FY2023 · CA · contact PI
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe$164,124
U54 · FY2023 · CA · contact PI
African Center for the Advancement of Research Excellence (AfriCARE)$258,384
P20 · FY2018 · CA
African Center for the Advancement of Research Excellence (AfriCARE)$273,496
P20 · FY2017 · CA